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Abstract. One of the contributory causes of colon cancer is
the negative effect of reactive oxygen species on DNA repair
mechanisms. Currently, there is a growing support for the
concept that oxidative stress may be an important etiological
factor for carcinogenesis. The purpose of this review is to
elucidate the role of oxidative stress in promoting colorectal
carcinogenesis and to highlight the potential protective role of
antioxidants. Several studies have documented the importance
of antioxidants in countering oxidative stress and preventing
colorectal carcinogenesis. However, there are conflicting data
in the literature concerning its proper use in humans, since
these studies did not yield definitive results and were
performed mostly in vitro on cell populations, or in vivo in
experimental animal models. 
Colorectal cancer (CRC) is classified as the 3rd most
common malignancy worldwide as it accounts for
approximately 9% of all cancer incidence worldwide,
moreover it is the 4th most prevalent cause of cancer
mortality (1, 2). Several pathways underlie CRC
pathogenesis, however, the main 3 routes are: the
chromosomal instability pathway (CIN), the microsatellite
instability pathway (MSI), and the serrated pathway (3). The
majority of CRCs arise from the CIN pathway, which is
characterized by defects in chromosomal segregation,
telomere stability, and the DNA damage response. On the
other hand, MSI derives from the loss of DNA mismatch
repair and is found in about 15% of all CRCs (2). Several risk
factors are related to the onset and progression of colorectal
cancer, such as environmental factors, physical inactivity,
smoking, alcohol consumption, diet and obesity among
others. A cross-talk between these known risk factors could
lead to oxidative stress, with an accompanying
overproduction of reactive oxygen species (ROS), that could
result in mutations and promote oncogenic phenotypes (1). In
CRC, the process of carcinogenesis involves complex
interactions between environmental and lifestyle factors
whereby multiple molecular pathways intersect to promote its
occurrence. However, genetic factors play a lesser role (up to
20% of cases). Risk factors for CRC include exposure to
toxins, regular consumption of alcohol, diet high in red meat
and saturated fat and low in fiber and vegetables, male
gender, older age, obesity, lack of physical exercise and
smoking (3). Despite the multiple factors responsible for its
onset, the incidence and prevalence of CRC increase more in
patients with with inflammatory bowel disease (IBD), such
as ulcerative colitis (UC) and Crohn’s disease (CD) (4, 5).
For UC patients, this risk might be linked mainly to the
disruption of the physiological balance in intestinal
microbiota (dysbiosis). Moreover, the duration and the extent
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of the disease in the colon, as well as the cumulative effects
of inflammation caused by continuous exposure of the
mucosa to inflammatory stimuli are among the leading factors
associated with the development of CRC in UC patients (6).
However, for CD patients, this risk is associated with
individual risk factors (7). Currently, it is clearly documented
that any dysregulation or imbalance of the gut microbiota
might lead to changes in colocytes as well as extraintestinal
disease (5, 6). This disruption causes an extensive and
persisting inflammatory reaction, manifested by up-regulation
of an array of pro-inflammatory mediators both locally and
systemically, such as; cyclooxygenase 2 (COX-2),
prostaglandin E2 (PGE2), tumor necrosis factor α (TNF-α),
nuclear factor kappa B (NFkB), and transforming growth
factor β (TGFβ) among others (8-10). Persistent
inflammatory reaction, in its turn, leads to the development
of IBD by activating the Gut Associated Lymphoid Tissue
(GALT) (4). Subsequently, the permeability and the integrity
of the intestinal mucosa are altered, thus exposing colocytes
to the action of pathogenic bacteria and mutagenic and
carcinogenic factors (6). The process of carcinogenesis starts
from dysplastic colocytes that begin to proliferate, giving rise
to adenomatous polyps. If these polyps are not detected and
removed in time, cancerised polyps and finally colorectal
cancer arise (2). This sequence of chronic inflammation -
dysplasia - adenoma - carcinoma was well described in 1988
by Vogelstein (11), who also reported the various mutations
involved in the pathogeneisis of CRC (Figure 1) (4).
In addition, the transition from adenoma to carcinoma
requires a set of molecular events such as the activation of
proto-oncogenes, inhibition of tumor suppressors, destruction
of the cellular matrix, DNA mutations and changes in DNA
methylation state (12). These DNA mutations are mostly
caused by oxidative stress, another important factor that is a
result ROS (1, 13). When they are not counterbalanced by
the antioxidant defenses of the cell, ROS cause an oxidative
stress and oxidative damage to the cell. This event may cause
DNA damage with subsequent mutations and chromosome
instability that, in turn, may lead to cancer (1, 3).
Role of Oxidative Stress
ROS, such as hydrogen peroxide, hydroxyl radical,
superoxide anion and peroxynitrite are derived from the
incomplete reduction of oxygen, as byproducts of normal
energy metabolism (13, 14). They are continuously
produced in aerobic organisms (14) from both endogenous,
such as mitochondria, cytochrome P450 metabolism,
peroxisomes or inflammatory cell activation, as well as
exogenous sources (14). Production of ROS is increased by
exposure to toxins, smoking, stress and inflammation caused
by metabolic diseases, diet, lifestyle factors and dysbiosis
(16). It has been estimated that one human cell is exposed
to approximately 1.5×105 oxidative hits a day (15). These
reactive species may react with biomolecules, such as lipids,
carbohydrates, proteins and nucleic acids, thereby,
interfering with cell function (14). As a result damage may
occur in the sequence of nucleotides causing DNA strand
breaks, oxidation of purine and pyrimidine bases, genetic
instability (13), and alterations in DNA methylation
resulting in chromosomal instability and aneuploidy. This
resulting oxidative damage is the first step involved in
mutagenesis, carcinogenesis and aging (3). The most
common oxidative DNA damage caused by ROS is
modification of the GC base pair, with subsequent base
substitutions, deletions and insertions (Figure 2) (13).
Another type of mutation associated with oxidative stress
and also present in CRC is DNA microsatellite instability
(MSI), which contributes to incorrect DNA repair mechanisms
during replication. MSI occurs when germline or sporadic
mutations in mismatch repair (MMR) genes allow for
replication errors or instability in repeat DNA sequences.
Microsatellite instability is classified as high frequency (MSI
- H) and low frequency (MSI - L), based on the percentage of
the loci that show instability. Studies have shown that oxidative
stress deactivates DNA repair systems, causing MSI - L and
development of CRC in patients with UC (1, 17). Moreover,
after the onset of cancer, ROS stimulates proliferation and
survival of cancer cells by promoting oncogenic phenotypes
(1) through the activation of various transcription factors (13).
Recently, the beneficial role of antioxidants found in food
or dietary supplements, in colorectal carcinogenesis has
become a topic of major interest. They exert their effects by
minimizing the genotoxic damage caused by the
accumulation of ROS, as well as by slowing cancer
progression. In this capacity, antioxidants would be acting as
long term chemopreventive agents (13-17).
Antioxidants 
Antioxidants are a group of substances that neutralize ROS.
They are also involved in several metabolic and molecular
processes implicated in the growth and invasiveness of tumor
cells (18, 19). Opposing oxidative stress by increasing
antioxidant activity is a potentially effective means of
delaying the harmful effects of ROS. For this reason, there
is a growing interest in recent years focused on the
assessment of the source, action, and potential health benefits
of dietary antioxidants (15).
The main available antioxidants are: polyphenols,
tocopherols, carotenoids, curcumin and vitamin C (Table I). 
Polyphenols. Polyphenols represent a broader class of
antioxidants and are found mostly in fruit, vegetables, tea,
wine, coffee and cereals. In plants, they are present in
glycosylated, esterified or polymerized form. Once ingested,
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Figure 1. Adenoma–carcinoma sequence. The sequence of facts that turn an adenomatous polyp into colorectal cancer. The transformation takes
place over a period of about ten years and is attributable to a set of mutations that are accumulating in the cell.
Figure 2. Effects of ROS on DNA. ROS are continuously generated from both endogenous sources as well as exogenous substances. The main DNA
damages produced by ROS are DNA strand breaks, genetic instability, changes in GC base pair and other. 
polyphenols undergo a set of changes both at the level of the
small intestine and colon, where 90-95 % of the absorption
takes place. Due to the activity of the intestinal microbiota,
dietary polyphenols are fragmented into easily absorbed
phenolic acids that are responsible for the beneficial effects
(20). Currently, it is estimated that 500-1,000 different
microbial species inhabit the gastrointestinal tract, reaching
the highest concentrations in the colon (up to 1012 cells per
gram of faeces). However, only a few bacterial species (e.g.
Escherichia coli, Bifidobacterium sp., Lactobacillus sp.,
Bacteroides sp., Eubacterium sp.) catalyzing the metabolism
of phenolics have been identified so far. Consequently, apart
from the inter-individual variation in daily intake of
polyphenols, inter-individual differences in the composition
of the gut microbiota might lead to differences in the
bioavailability and bioefficacy of polyphenols and their
metabolites (20-23). Some of the beneficial effects of
polyphenols on intestinal microbiota are reinforcement of the
tight junctions between intestinal mucosal cells, an anti-
tumoral effect, and modulation of the immune system
resulting in an anti-inflammatory effect (21, 27). Polyphenols
exert their effects through different mechanisms, such as
decrease of cancer cell proliferation, apoptosis induction,
reduction of angiogenesis and inflammation (25) and
inhibition of specific signaling pathways such as the Wnt/β
– catenin pathway (26, 27). Some of the most common
polyphenols are quercetin, anthocyanins, catechins, and
resveratrol (Table II) (21, 24, 27, 28).
Quercetin (3,3’,4’,5,7-pentahydroxyflavone) is one of the
major dietary flavonoids and polyphenols found in several
fruit, vegetables, and beverages such as tea and wine. This
nutraceutical is known as phytoestrogen for its molecular
similarity with the 17β-Estrogen. It has been shown that
quercetin plays a role in inhibiting tumorigenesis in colon
cells through antioxidant, anti-inflammatory, antiproliferative
and pro-apoptotic mechanisms (27). It is able to inhibit cell
proliferation of CRC in vitro, by modulating the activity and
expression of the estrogen receptor ERβ (28, 29). On HT-29
cells, quercetin decreased significantly cell viability, induced
cell-cycle arrest in the G1 phase, and increased the
expression of apoptosis related proteins, such as AMPK, p53,
and p2 (30).
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Table I. Main available antioxidants.
Type of antioxidants         Where they are found                                                                  Potential beneficial effects
Polyphenols                      Fruit, vegetables, tea, wine, coffee and cereals                         Anti-tumoral effect, modulation of the immune 
                                                                                                                                                system, reduction of intestinal inflammation.
Tocopherols                      Vegetable oil, soybean, nuts and corn                                        Countering the action of ROS, prevention of the formation 
                                                                                                                                                of cell colonies, reduction of inflammation.
Carotenoids                       Carrots, oranges, tangerines, tomatoes,                                     Anti-tumoral activity, modulation of the migration and 
                                          spinach and broccoli                                                                    invasiveness of colorectal cancer cells.
Curcumin                          Oriental spice, frequently consumed in Indian,                        Inhibition of tumor initiation, promotion, invasion and 
                                          Pakistanian and Thai cooking                                                     metastasis, involvement in the modulation of 
                                                                                                                                                DNA methylation.
Vitamin C                         Fresh vegetables and fruit (as lemon, strawberry,                    Reducing capacity, down-regulation of metastasis, 
                                          spinach, orange)                                                                           induction of apoptosis.
Table II. Subclasses of polyphenols.
Type of polyphenols         Where they are found                                                                  Potential beneficial effects
Quercetin                          Fruit, vegetables, tea and wine                                                   Inhibition of tumorigenesis through antioxidant, 
                                                                                                                                                anti-inflammatory, antiproliferative, and 
                                                                                                                                                pro-apoptotic mechanisms.
Anthocyanins                    Red, blue and purple fruit as blueberries,                                 Anti-aging and anti-free radical effects, inhibition of 
                                          strawberries and raspberries                                                        tumor growth, reduction of oxidative stress and 
                                                                                                                                                down-regulation of inflammatory mediator expression.
Catechins                          Green tea (Camelia sinensis)                                                      Suppression of cancer stem cells, potent 
                                                                                                                                                anti-oxidant activity.
Resveratrol                        Red wine and grapes                                                                   Anti-inflammatory and antioxidant effects, inhibition 
                                                                                                                                                of cell proliferation, induction of apoptotic mechanisms.
Anthocyanins, (Greek anthos=flower and kyanos=blue)
are water-soluble pigments responsible for the red, blue and
purple color of some fruit (such as blueberries, strawberries
and raspberries). In plant cells, they are present in vacuoles
in the form of various sized granules. Numerous recent
studies are shedding light on these pigments as dietary
components with preventive impact on cancer as well as
effective, cheap and safe anticancer supplements. They also
seem to have anti-aging and anti-free radical effects (31-33).
Furthermore, anthocyanins derived from sweet potato were
shown to inhibit the development of CRC (34). This
compound was able to induce anti-proliferative and apoptotic
mechanisms as well as cell cycle arrest both in vivo and in
vitro (31). Finally, anthocyanins present in black raspberry
are able to inhibit the growth of cancer cells in vitro through
the demethylation of tumor suppressor genes (32).
Catechins, found predominantly in green tea (Camelia
sinensis), are regularly consumed in many Asian countries
as a traditional medicine with multiple health benefits to
improve blood circulation, wound healing, and digestion. Its
principal extract Epigallocatechin-3-gallate (EGCG) has been
shown to be a potent anti-oxidant which acts through
chelating metal ions (26). Recently, EGCG has been shown
to suppress cancer stem cells (CSCs), which are a small
subset of cells playing a major role in chemoresistance and
tumor recurrence. By targeting CSCs, EGCG was able to
enhance fluorouracil (5-FU) sensitivity in chemoresistant
CRC. Thus, the use of this natural product may provide a
safe and effective adjunct approach in overcoming
conventional chemotherapy resistance in colorectal
carcinogenesis (35).
Resveratrol is a compound found in various foods
including red wine and grapes (especially the peel of the
grape berries). It has been shown that resveratrol has anti-
inflammatory and antioxidant effects. It acts mainly through
the inhibition of cell proliferation, induction of apoptotic
mechanisms, and down-regulation of K-ras (12). 
Tocopherols. Tocopherols, better known as vitamin E, are a
group of fat-soluble compounds found in foods such as
vegetable oil (i.e. sesame oil, canola oil, and sunflower oil),
soybean, nuts and corn (25). Structurally, they occur in α, β, γ
and δ –form, determined by the position and number of methyl
groups on the chromanol ring (25, 36). Their antioxidant
activity is expressed at the level of cell membrane by countering
the action of ROS on its lipid bilayer, thus playing a protective
role against ROS-induced carcinogenesis (25). Particularly δ-
tocopherol has the highest inhibitory activity on CRC cells
among the other family members, inducing apoptosis and
preventing the formation of cell colonies (37, 38). Moreover, γ-
tocopherol reduced inflammation in a moderate colitis and,
consequently, reduced the risk of progression to cancer (36).
Furthermore, γ and δ-tocopherols were able to inhibit
carcinogenesis in a mouse model of colorectal cancer by
reducing the inflammatory reaction and preventing the
formation of dysplasia and aberrations (Table III) (25).
In brief, metabolites resulting from the processing of
intestinal tocopherols have anti-inflammatory effects. These
end-products act through the inhibition of COX and
lipoxygenase, therefore, they might be useful in the reduction
of chronic inflammation in IBD and subsequently CRC
prevention (36).
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Table III. Subclasses of tocopherols.
Type of tocopherols         Where they are found                                                                  Potential beneficial effects
δ-Tocopherol                    Vegetable oil (sesame oil, canola oil, sunflower oil)                 Induction of apoptosis and prevention of cell 
                                                                                                                                                colony formation.
γ-Tocopherol                    Vegetable oil (sesame oil, canola oil, sunflower oil)                 Reduction of inflammation and consequently, 
                                                                                                                                                reduction of the risk of cancer progression. 
Table IV. Subclasses of carotenoids with anticancer effects.
Type of tocopherols         Where they are found                                                                  Potential beneficial effects
α- and β-Carotene            Orange foods such as carrots                                                      β-Carotene, in the form of retinol: Inhibition of tumor 
                                                                                                                                                cell invasiveness and ability to migrate through 
                                                                                                                                                the extracellular matrix
Lycopene                          Tomatoes                                                                                     Inhibition of growth factors, angiogenesis, and apoptosis
Carotenoids. Carotenoids are a group of yellow, orange,
and red fat-soluble pigments, that are divided into two main
groups: Those with pro-vitamin activities (vitamin A) that
include α- and β-carotenes (found mainly in orange foods
such as carrots) and β-cryptoxanthin (found in citrus foods
such as oranges and tangerines), and those without pro-
vitamin activities, which include lycopene (present in large
quantities in tomatoes), lutein, and zeaxanthin (found in
green foods such as spinach and broccoli) (39). Numerous
studies have demonstrated the antioxidant activity of
carotenoids and their potential role in reducing the risk of
developing colon cancer. β-Carotene, once ingested,
undergoes several enzymatic processes that transform it
firstly into retinaldehyde and subsequently retinol (also
known as vitamin A). Retinol is able to inhibit the
invasiveness of tumor cells and their ability to migrate
through the extracellular matrix. An increase of dietary β-
carotene intake might have an antitumor effect due to the
ability of β-carotene to modulate the migration and
invasiveness of CRC cells. β-Carotene is the substrate of
the enzyme β-carotene 15,15’-monooxygenase, which is
inhibited in preneoplastic intestine leading to an increased
expression of matrix metalloproteinases and subsequently
an increased tumor invasiveness. β-Carotene has been
shown to up-regulate the inhibited enzyme in colon cancer
cells, in vitro, thus presenting antitumor effects (40, 41)
(Table IV). Among other carotenoids, lycopene also exerts
anti-inflammatory activity resulting in the suppression of
inflammation-associated promotion and progression of
carcinogenesis, inhibition of cell invasion, angiogenesis and
metastasis (39). However, conflicting data concerning
carotenoids exist, for example studies on the association
between increased consumption of dietary carotenoids and
reduced risk of CRC have not yielded any significant
results (40-42).
Curcumin. Curcumin, one of the active ingredients in
turmeric (Curcuma longa), is a common oriental spice that
gives the curry powder its yellowish color. It is more
frequently consumed in Indian, Pakistanian and Thai
cooking. Curcumin exerts a powerful anti-inflammatory
activity by interacting with different molecular mechanisms
such as transcription factors, regulatory proteins, and
enzymes in addition to antifungal, antibacterial and
anticancer properties. Curcumin acts at several stages of
cancer development. It inhibits tumor initiation, promotion,
invasion and metastasis as revealed in several studies (2, 3).
This antioxidant is also involved in the modulation of DNA
methylation in colon cancer cells and thus seems to have
chemopreventive effects. For this reason, this nutraceutical
is currently the focus of numerous studies shedding light on
its role in various chronic conditions including autoimmune,
cardiovascular, neurological, and most importantly by being
a promising chemopreventive natural agent with numerous
targets and no reported adverse or toxic effects (2, 3). 
Vitamin C. Vitamin C (ascorbic acid) is an acidic polyol with
six carbon atoms and α-keto mycolactone. It is mainly found
in fresh vegetables and fruit. The antioxidant ability of
vitamin C is reflected by its reducing capacity, which means
it can directly and rapidly react with the superoxide ion O2
− and singlet oxygen through dehydrogenation. Its serum
concentration in healthy humans is 48.3-79.5 μmol/l (43). In
recent years, a large number of basic and clinical studies
showed that vitamin C plays an important role in a series of
diseases caused by oxidative stress, such as cardiovascular
disease and cancer. Vitamin C was also shown to have an
effective role in the treatment and prevention of cancer. The
exact pathways through which this molecule exerts its
antitumorigenic effect are not well defined. However, the
main mechanisms are the induction of apoptosis via the
disruption of mitochondrial membrane potential, as well as
the suppression of cancer cell proliferation through cell-cycle
arrest at G1 stage, leading to the modulation of the activity
of p53-p21Waf1/Cip1 and CDK2 (44). Vitamin C has been
shown to have an antitumor activity, as the exposure to high
levels of vitamin C led to cell death of human CRC cells
harboring KRAS or BRAF mutations, in vitro. In particular,
it appears that oxidized form of vitamin C, dehydroascorbate
(DHA), has selective toxicity to cancer cells through redox
homeostasis desruption, though the exact mechanism of
action remains unclear (45). However, it is possible to
hypothesize that since more than half of human CRCs carry
either KRAS or ,0 mutations, and are often refractory to
approved targeted therapies, Vitamin C might be a promising
therapeutic agent in colorectal carcinogenesis (44, 45).
Conclusion
It is well-documented that one of the contributory causes of
colon cancer is the effect of oxidative stress on the DNA
sequence resulting in the eventual progression of adenoma
to carcinoma. Studies on the action of antioxidants on
oxidative stress and on CRC are not always in agreement,
however, the positive health effects of antioxidants on CRC
have always been implicated. Consequently, antioxidants are
being consumed on almost routine basis in patients with
CRC. This is despite the fact that no direct human data have
been confirmed. However, data emanating from in vitro
studies and from animal models are encouraging in
decreasing the rate of progression of CRC. Therefore, larger
studies involving CRC patients are required to further
elucidate the importance of dietary antioxidants on colorectal
carcinogenesis. In brief, at this point, the use of antioxidants
could be recommended and justified to patients with history
of IBD and CRC.
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